LIVE: Perinatal Psychiatry: Treatment During Pregnancy and the Postpartum 2021
Now Virtual!
Please click Take Course in the tab above to log into your account so you may begin your evaluation, claim credits, and access the videos.Please email mghcme@mgh.harvard.edu with any questions or concerns. |
This virtual conference will focus on the diagnosis and treatment of psychiatric disorders in women across pregnancy and the postpartum. Specialized knowledge is necessary to tailor treatments to reproductive events such as pregnancy, pregnancy planning, and the postpartum. Exposure to psychotropic medications and the consequence of untreated psychiatric disorders must be considered when treating pregnant women, those who may become pregnant during treatment, and those who are breastfeeding. Up to date and comprehensive knowledge is required to help patients make collaborative and individualized treatment decisions. A strong understanding of the literature pertaining to the reproductive safety of medications is imperative to factoring in potential risks and benefits of medication, and context is particularly critical in putting risks into perspective. Focused material will also be presented regarding specialized psychotherapies utilized during pregnancy and the postpartum, as well as an overview of embryology and obstetrics informing a broad range of care modalities
This program is eligible for 1.5 Risk Management Credits.
Pricing
Women’s Mental Health: $250
PSYCHOPHARMACOLOGY AND WOMEN’S MENTAL HEALTH BUNDLED PRICING (SAVINGS OF $55)
MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before August 4, 2021) = $744
Early Bird Registration (on or before September 4, 2021) = $849
Regular Registration (after September 4, 2021) = $899
Other Professionals or Trainees
Super Early Bird Registration (on or before August 4, 2021) = $504
Early Bird Registration (on or before September 4, 2021) = $609
Regular Registration (after September 4, 2021) = $659
***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.
If you are interested in attending Perinatal Psychiatry AND the Psychopharmacology conference you can register for all sessions by clicking here.
Syllabus
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 1, 2021. No refunds will be issued for refund requests made after October 1, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Target Audience
This program is intended for:
- practicing psychiatrists
- primary care physicians
- social workers
- psychologists
- nurse practitioners
- licensed mental health counselors
- nurses
- prescribing nurse practitioners
Learning Objectives
Psychiatric Disorders During Pregnancy
- Discuss critical research findings in reproductive psychiatry that inform clinical care
- Describe the current knowledge gaps in reproductive psychopharmacology over the last decade
- Explain current treatment algorithms for screening and treatment of psychiatric disorders during pregnancy
Postpartum Mood and Anxiety Disorders
- Describe and apply the risks/benefits safety of psychiatric medication during the postpartum and breastfeeding context
- Identify strategies for screening and treatment of postpartum depression
- Define the presentation and treatment of postpartum psychosis; and describe and assess the vulnerability for mood episodes in women with bipolar disorder and acute treatment and preventative strategies
Sorting Through the Data: Where do patients and providers go for information?
- Identify reliable resources for information on the reproductive safety of medications
- Discuss the strengths and limitations of the Pregnancy and Lactation Labeling Rule (PLLR)
- Use basic tools for the evaluation of reproductive safety data in the medical literature
Substance Abuse in Pregnancy and the Postpartum
- Discuss the pharmacologic treatments of substance us disorders in pregnant and postpartum women
- Explain the importance of screening, assessment and treatment of comorbid psychiatric conditions in women with SUD
- Describe the psychosocial and environmental factors in the practice of “low barrier psychiatry” for pregnant and postpartum women with substance use disorders
Specialized Psychotherapies for Pregnancy and Postpartum
- Discuss the types and value of psychotherapy in consideration of perinatal mental health
- Describe the research on evidence-based psychotherapy for perinatal mental health
- Identify common barriers to psychotherapy and novel strategies to address the gaps in perinatal mental health treatments
Medication Teratogenesis and Pregnancy Complications
- Identify the timing and impact of medication exposures on fetal development
- Describe the knowledge gaps in our understanding of medication safety
- Demonstrate a general understanding of common obstetrical complications
Women’s mental health
OCTOBER 21, 2021
Virtual Event
Conference will be held in Eastern Standard Time (EST)
THURSDAY, OCTOBER 21, 2021
8:30-8:45 AM Welcome & Introduction
Lee S. Cohen, MD and Marlene P. Freeman, MD
8:45-9:30 AM Psychiatric Disorders During Pregnancy
Lee S. Cohen, MD
9:30-10:15 AM Postpartum Mood and Anxiety Disorders
Marlene P. Freeman, MD
10:15-10:30 AM Question & Answer
Lee S. Cohen, MD and Marlene P. Freeman, MD
10:30-10:45 AM Break
10:45-11:30 AM Sorting Through the Data: Where do patients and providers go for information?
Ruta Nonacs, MD, PhD
11:30-12:15 PM Substance Use Disorders in Pregnancy and the Postpartum
Edwin Raffi, MD, MPH
12:15-12:30 PM Question & Answer
Ruta Nonacs, MD, PhD and Edwin Raffi, MD, MPH
12:30-1:30 PM Break
1:30-2:15 PM Specialized Psychotherapies for Pregnancy and the Postpartum
Rachel Vanderkruik, PhD, MSc
2:15-3:00 PM Medication Teratogenesis and Pregnancy Complications
Sarah Bernstein, MD
3:00-3:15 PM Question & Answer
Rachel Vanderkruik, PhD, MSc and Sarah Bernstein, MD
3:15-3:30 PM Conclusion & Closing Remarks
Lee S. Cohen, MD and Marlene P. Freeman, MD
Marlene Freeman, MD
Marlene Freeman, MD
Available Credit
- 5.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 5.75 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 5.75 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 5.50 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 5.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 90436-2
- 5.75 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 5.75 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 5.75 Continuing Education (CE) credits per presentation for psychologists.
Price
If you are interested in attending Psychiatric Disorders in Women AND the Psychopharmacology conference you can register for all sessions by clicking here.